Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.340
0.00 (0.00%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Entero Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 3.43 | 3.71 | 1.36 | 8.25 | 6.06 | 0.18 | Upgrade
|
| Cash & Short-Term Investments | 3.43 | 3.71 | 1.36 | 8.25 | 6.06 | 0.18 | Upgrade
|
| Cash Growth | 66.24% | 172.34% | -83.48% | 36.07% | 3348.40% | -84.22% | Upgrade
|
| Other Receivables | - | - | 0.09 | - | 0.55 | 2.64 | Upgrade
|
| Receivables | - | - | 0.09 | - | 0.55 | 2.64 | Upgrade
|
| Prepaid Expenses | 4.06 | 1.24 | 1.96 | 1.18 | 1.26 | 0.6 | Upgrade
|
| Total Current Assets | 7.49 | 4.96 | 3.41 | 9.42 | 7.87 | 3.41 | Upgrade
|
| Property, Plant & Equipment | 0.21 | 0.21 | 0.3 | 0.41 | 0.09 | 0.16 | Upgrade
|
| Goodwill | 20.04 | 1.68 | 1.68 | 1.91 | 2.05 | 1.89 | Upgrade
|
| Other Intangible Assets | 0.37 | - | - | - | 2.88 | 3.41 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.04 | Upgrade
|
| Total Assets | 91.13 | 6.88 | 5.44 | 11.79 | 12.92 | 8.9 | Upgrade
|
| Accounts Payable | 2 | 0.55 | 0.72 | 2.71 | 1.56 | 1.8 | Upgrade
|
| Accrued Expenses | 2.55 | 0.83 | 0.32 | 0.39 | 0.13 | 0.48 | Upgrade
|
| Short-Term Debt | 0.39 | 0.61 | 0.6 | 0.64 | 0.55 | 1.52 | Upgrade
|
| Current Portion of Leases | 0.07 | 0.07 | 0.07 | 0.08 | 0.06 | 0.08 | Upgrade
|
| Other Current Liabilities | 1.16 | 1.07 | 0.77 | 8.48 | 13.25 | 0.39 | Upgrade
|
| Total Current Liabilities | 6.17 | 3.13 | 2.48 | 12.3 | 15.55 | 4.29 | Upgrade
|
| Long-Term Debt | 6.4 | - | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.13 | 0.15 | 0.21 | 0.31 | 0.02 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 7 | - | - | Upgrade
|
| Total Liabilities | 13.27 | 3.28 | 2.7 | 19.61 | 15.56 | 4.29 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 194.94 | 187.93 | 171.28 | 147.31 | 93.84 | 68.58 | Upgrade
|
| Retained Earnings | -178.76 | -184.33 | -168.53 | -153.9 | -95.37 | -62.69 | Upgrade
|
| Comprensive Income & Other | - | - | - | -1.22 | -1.11 | -1.27 | Upgrade
|
| Total Common Equity | 16.18 | 3.6 | 2.74 | -7.82 | -2.64 | 4.62 | Upgrade
|
| Shareholders' Equity | 77.86 | 3.6 | 2.74 | -7.82 | -2.64 | 4.62 | Upgrade
|
| Total Liabilities & Equity | 91.13 | 6.88 | 5.44 | 11.79 | 12.92 | 8.9 | Upgrade
|
| Total Debt | 6.98 | 0.83 | 0.88 | 1.03 | 0.63 | 1.6 | Upgrade
|
| Net Cash (Debt) | -3.55 | 2.88 | 0.48 | 7.22 | 5.43 | -1.43 | Upgrade
|
| Net Cash Growth | - | 502.02% | -93.36% | 32.86% | - | - | Upgrade
|
| Net Cash Per Share | -4.75 | 8.58 | 13.34 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 2.48 | 2.03 | 0.08 | - | - | - | Upgrade
|
| Total Common Shares Outstanding | 2.03 | 1.56 | 0.05 | - | - | - | Upgrade
|
| Working Capital | 1.32 | 1.82 | 0.93 | -2.88 | -7.68 | -0.88 | Upgrade
|
| Book Value Per Share | 7.99 | 2.31 | 55.12 | - | - | - | Upgrade
|
| Tangible Book Value | -4.22 | 1.92 | 1.06 | -9.73 | -7.57 | -0.68 | Upgrade
|
| Tangible Book Value Per Share | -2.08 | 1.23 | 21.27 | - | - | - | Upgrade
|
| Machinery | 0.08 | 0.06 | 0.06 | 0.06 | 0.03 | 0.31 | Upgrade
|
| Leasehold Improvements | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.